Table 3.
S no | Category | Sub-category | Score |
1 | Time of onset from beginning the drug | (>90 days) | +1 |
2 | The course of ALT after cessation of the drug | >50% reduction in 8 days | NA |
3 | Risk factors | Age >55 years | +1 |
4 | Concomitant drug | None | 0 |
5 | Search for an alternative cause | All 7 causes of the group-I ruled out (HAV, HCV, HEV, alcoholism-AST/ALT level, sonography, Doppler of hepatic vessels and a recent episode of hypotension. All 5 causes of the group-II ruled out (VZV, CMV, EBV, HSV< and underlying precipitating condition) |
+2 |
6 | Previous hepatotoxicity to the same drug | Unknown | 0 |
7 | Response to unintentional re-exposure | None | 0 |
Total score | 1–2=unlikely 3–5=possible 6–8=probable 9 or more=highly probable |
+4 (3–5=possible cause) |
ALT, alanine transaminase; AST, aspartate transaminase; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus;HEV, hepatitis E virus; HSV, herpes simplex virus; VZV, varicella-zoster virus.